SCHEMBL6904992

SCHEMBL6904992

CC1CN(C(=O)O)CCN1c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.55
ADAMTS5 Q9UNA0 8/20 0.53
SLC18A3 Q16572 1/20 0.51
GFER P55789 3/20 0.50
MMP2 P08253 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
SLC6A7 Q99884 1/20 0.48
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17746120 0.87 MAPT (0.47) MAPK1ADAMTS5GFERMMP2SMN1; SMN2
SCHEMBL29748819 0.86 GFER (0.63) GFERSMN1; SMN2SLC6A7
SCHEMBL6912788 0.86 GFER (0.46) MAPK1ADAMTS5GFERMMP2SMN1; SMN2
SCHEMBL27208470 0.86 GFER (0.46) MAPK1ADAMTS5GFERMMP2SMN1; SMN2
SCHEMBL27208320 0.86 GFER (0.46) MAPK1ADAMTS5GFERMMP2SMN1; SMN2
SCHEMBL23777784 0.85 ADAMTS5 (0.56) ADAMTS5GFERMMP2SMN1; SMN2LMNA
SCHEMBL23777622 0.85 GFER (0.70) MAPK1GFERSMN1; SMN2LMNAMAPT
SCHEMBL23777843 0.85 ADAMTS5 (0.56) ADAMTS5GFERMMP2SMN1; SMN2LMNA
SCHEMBL23777709 0.85 GFER (0.70) MAPK1GFERSMN1; SMN2LMNAMAPT
SCHEMBL23777781 0.85 ADAMTS5 (0.56) ADAMTS5GFERMMP2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-6825200-B1 TREATING, PROLONGING, OR EXTENDING THE ONSET OF ORGAN REJECTION IN A HUMAN DURING OR AFTER ORGAN TRANSPLANTATION IN A HUMAN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
EP-1226159-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-31 EP disclosed
WO-2001032690-A1 SUBSTITUTED DIPEPTIDES HAVING NOS INHIBITING ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-10 WO disclosed